Acessibilidade / Reportar erro

A Rare Subtype of a Rare Tumor

Heart Neoplasms/surgery; Mitral Valve/surgery; Diagnostic, Imaging/methods; Heart Failure/complications; Multimodal Imaging/methods, Leiomyosarcoma/surgery

A 71-year-old woman was admitted to our center, complaining of fatigue, dyspnea, and anorexia. Physical examination revealed a grade III low-pitched diastolic murmur at the mitral focus. Transthoracic echocardiogram (TTE) showed an oval mass inside the left atrium (LA) extending from its roof to the mitral valve ( Figure 1A ), causing significant transmitral pressure gradient ( Figure 1B ). Transesophageal echocardiogram (TEE) ( Figure 1C ) raised the suspicion of left superior pulmonary vein involvement, which was confirmed by computed tomography (CT) angiography ( Figure 1D ). Cardiac magnetic resonance imaging characterized the mass as isointense on T1 and hyperintense on T2-weightened images; there was a contrast uptake, in first-passage sequences, and a heterogeneous late gadolinium enhancement ( Figure 2A-D ).

Figure 1
– Echocardiography and computed tomography. (A) TTE four-chamber view revealing an oval mass (*) inside the LA. (B) zoom and color comparison of the LA and left ventricle inflow tract, demonstrating a diastolic pressure gradient. (C) TEE, raising the suspicion of left superior pulmonary vein and left atrial appendage involvement. (D) Thoracic CT scan confirming pulmonary vein invasion by the mass.

Figure 2
– Cardiac magnetic resonance imaging. (A) T1-weighted image revealing an isointense mass (*). (B) T2-weighted image with the mass appearing as hyperintense. (C) Contrast uptake in first-passage sequences. (D) Heterogeneous late gadolinium enhancement.

The patient was referred for the surgical removal of the mass ( Figure 3A ). Upon histologic examination, the mass consisted of a highly cellular malignant neoplasm with pleomorphic spindle cells and bizarre nuclei ( Figure 3B ). Immunohistochemical analysis revealed a diffuse staining pattern for desmin ( Figure 3C ), smooth muscle actin ( Figure 3D ), and h-Caldesmon ( Figure 3E ). Nuclear staining for MDM2 was multifocal ( Figure 3F ). Globally, these features suggested the diagnosis of leiomyosarcoma. Although the surgery had no immediate complications, the patient died on the 14thpost-operative day due to septic shock secondary to a nosocomial respiratory tract infection.

Figure 3
– Surgical specimen and histopathological study. (A) Excised surgical specimen. (B) HE 200x revealing a highly cellular tumor composed of pleomorphic spindle cells with a high mitotic index. (C) Staining pattern for desmin. (D) Staining pattern for smooth muscle actin. (E) Staining pattern for h-Caldesmon. (F) Nuclear staining for MDM2.

Cardiac tumors are rare and most often benign.11. Paraskevaidis IA, Michalakeas CA, Papadopoulos CH, Anastasiou-Nana M. Cardiac tumors. ISRN Oncol. 2011;2011:208929. doi: 10.5402/2011/208929 Clinical presentation depends on the location, dimension, and mobility of the mass. Sarcomas account for most primary malignant heart tumors. These are usually aggressive and overall prognosis is poor,22. Neragi-Miandoab S, Kim J, Vlahakes GJ. Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol (R Coll Radiol). 2007;19(10):748-56. doi: 10.1016/j.clon.2007.06.009 with a median survival of about 9 months.33. Oliveira GH, Al-Kindi SG, Hoimes C, Park SJ. Characteristics and Survival of Malignant Cardiac Tumors: A 40-Year Analysis of >500 Patients. Circulation. 2015;132(25):2395-402. doi: 10.1161/CIRCULATIONAHA. 115.016418 Noninvasive imaging techniques play a crucial role in the diagnostic workup, enabling location and tissue characterization of the mass, as well as an evaluation of the functional impairment and involvement of surrounding structures. All of these features contribute to a better surgical planning. However, these do not differentiate between histological subtypes.44. Basso C, Rizzo S, Valente M, Thiene G. Cardiac masses and tumours. Heart. 2016;102(15):1230-45. doi: 10.1136/heartjnl-2014-306364 Currently, the only treatment with survival benefit is surgical resection.55. Hoffmeier A, Sindermann JR, Scheld HH, Martens S. Cardiac tumors--diagnosis and surgical treatment. Dtsch Arztebl Int. 2014;111(12):205-11. doi: 10.3238/arztebl.2014.0205

Referências

  • 1
    Paraskevaidis IA, Michalakeas CA, Papadopoulos CH, Anastasiou-Nana M. Cardiac tumors. ISRN Oncol. 2011;2011:208929. doi: 10.5402/2011/208929
  • 2
    Neragi-Miandoab S, Kim J, Vlahakes GJ. Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol (R Coll Radiol). 2007;19(10):748-56. doi: 10.1016/j.clon.2007.06.009
  • 3
    Oliveira GH, Al-Kindi SG, Hoimes C, Park SJ. Characteristics and Survival of Malignant Cardiac Tumors: A 40-Year Analysis of >500 Patients. Circulation. 2015;132(25):2395-402. doi: 10.1161/CIRCULATIONAHA. 115.016418
  • 4
    Basso C, Rizzo S, Valente M, Thiene G. Cardiac masses and tumours. Heart. 2016;102(15):1230-45. doi: 10.1136/heartjnl-2014-306364
  • 5
    Hoffmeier A, Sindermann JR, Scheld HH, Martens S. Cardiac tumors--diagnosis and surgical treatment. Dtsch Arztebl Int. 2014;111(12):205-11. doi: 10.3238/arztebl.2014.0205
  • Study Association
    This study is not associated with any thesis or dissertation work.
  • Sources of Funding: There were no external funding sources for this study.

Publication Dates

  • Publication in this collection
    27 Feb 2023
  • Date of issue
    2023

History

  • Received
    03 July 2022
  • Reviewed
    18 Oct 2022
  • Accepted
    14 Dec 2022
Sociedade Brasileira de Cardiologia - SBC Avenida Marechal Câmara, 160, sala: 330, Centro, CEP: 20020-907, (21) 3478-2700 - Rio de Janeiro - RJ - Brazil, Fax: +55 21 3478-2770 - São Paulo - SP - Brazil
E-mail: revista@cardiol.br